SA
DGX icon

SpiderRock Advisors’s Quest Diagnostics DGX Stock Holding History

SpiderRock Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$300K Hold
1,932
– – ﹤0.01% 733
2024
Q2 		$265K Sell
1,932
-14
-0.7% -$1.92K 0.01% 687
2024
Q1 		$249K Buy
+1,946
New +$252K 0.01% 652

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

SpiderRock Advisors's DGX Position: Q3 2024 in Review

SpiderRock Advisors held its Quest Diagnostics (DGX) position steady in Q3 2024 at 1,932 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

SpiderRock Advisors first reported a position in DGX in Q1 2024 and has held it in 3 quarters since. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • SpiderRock Advisors held 1,932 shares of Quest Diagnostics worth $300K as of Q3 2024.
  • SpiderRock Advisors left its Quest Diagnostics share count unchanged in Q3 2024.
  • Quest Diagnostics made up ﹤0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #733 holding.
  • SpiderRock Advisors first reported a position in Quest Diagnostics in Q1 2024 and has held it in 3 quarters since.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.